Form: EFFECT

Notice of Effectiveness

January 23, 2024

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Notice of Effectiveness

Effectiveness Date: January 23, 2024 4:30 P.M.
Form: S-3
CIK: 0001228627
Company Name: Ocuphire Pharma, Inc.
File Number: 333-276462